Insomnia Disorder Clinical Trial
Official title:
The Effect of Individualised Homeopathic Treatment of Insomnia Disorder in Females
In South Africa, 27% of adult males and 31% of adult females experience insomnia. Insomnia may lead to feelings of fatigue and sleepiness, mood disturbances, cognitive difficulties, and may exacerbate symptomatology of co-morbid diseases. Current conventional treatment for insomnia includes both psychological and drug therapies. These conventional medications potentially may lead to dependency and withdrawal symptoms. Individualised homeopathic treatment is a process in which a homeopath selects the most appropriate remedy for the treatment of a condition in accordance with the fundamental principles of homeopathy. This treatment protocol may offer safe and effective treatment for insomnia disorder, however, more research is required on the subject. The aim of this study is to determine the effect of individualised homeopathic treatment of insomnia disorder in females using detailed case studies and the Insomnia Severity Index.
This study will be of an embedded mixed method case study design, conducted at the
University of Johannesburg Doornfontein Homeopathic Health Clinic over a period of 8 weeks.
Ten female participants, aged 18 to 45 years, will be recruited by means of non-probability
purposive sampling via advertisements placed in the University of Johannesburg Homeopathic
Health Clinic and in pharmacies around Johannesburg, with the relevant permission given.
The nature of the study, as well as the requirements for participation will be fully
explained and the volunteers will be asked to sign the Participant Information and Consent
Form once they agree to participate. Potential participants will undergo a brief screening
to determine if they meet the requirements for this study. The participants that meet the
inclusion criteria will attend the initial consultation and those that do not meet the
inclusion criteria will be referred to the Homeopathic Health Clinic.
The consultation will consist of a comprehensive homeopathic case history, the conduction of
relevant physical exams, including vital signs, and the completion of the Insomnia Severity
Index (ISI). The participant's case will be analysed and computer repertorised, using the
Complete Repertory of Mercurius homeopathic software (Aeon Group), version 5.3.0.17. The
individualised homeopathic remedy will be selected by the researcher who will refer to the
appropriate Materia Medica. The Homeopathic Dispenser will dispense the homeopathic remedy
to the participant.
Each participant will return for four follow-up consultations which will be two weeks apart.
At each follow-up consultation the ISI will be completed and a follow-up case history and
physical examination of the participants' vital signs will be conducted. The participants'
symptoms will be re-evaluated and a remedy prescribed accordingly. At the final consultation
in the 8th week, no remedy will be prescribed.
Data will be collected and analysed by the researcher with the assistance of a statistician
at Statkon, using non-parametric tests, including: frequencies and descriptives, the
Friedman test, and Wilcoxon post hoc test.
The possible outcome of this study may demonstrate that individualised homeopathic treatment
is effective in reducing the frequency and intensity of insomnia disorder in females, and
instigate further research on the subject.
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00821041 -
Internet-based Treatment for Chronic Insomnia
|
Phase 2 | |
Completed |
NCT03727438 -
Provider Supported Self-Help Cognitive Behavioral Therapy for Insomnia (Tele-Self CBTI)
|
N/A | |
Recruiting |
NCT03633305 -
Optimization of Insomnia Treatment in Primary Care
|
N/A | |
Completed |
NCT04616157 -
Internet-based Cognitive Behavioral Therapy for Adolescents With Sleep Problems- a Feasibility Trial
|
N/A | |
Completed |
NCT03679884 -
Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep
|
Phase 3 | |
Completed |
NCT02839200 -
Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder
|
Phase 2 | |
Recruiting |
NCT04752254 -
Investigating Racing Thoughts in Patients With Insomnia Disorder
|
||
Completed |
NCT05541055 -
Digital CBT-I for Insomnia Disorder
|
N/A | |
Completed |
NCT05558865 -
Effectiveness of a Digital Health Application for People With Insomnia Disorder (Somnovia)
|
N/A | |
Active, not recruiting |
NCT06393504 -
Database Study to Provide Information on Pregnancy and Infant Outcomes Among Women Exposed to QUVIVIQ (Daridorexant)
|
||
Completed |
NCT02841709 -
Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder
|
Phase 2 | |
Completed |
NCT03328585 -
Telemedicine vs. In-person Delivery of Cognitive Behavioral Treatment of Insomnia: a Mixed Methods Analysis
|
N/A | |
Completed |
NCT02952820 -
Long-term Study of Lemborexant in Insomnia Disorder (SUNRISE 2)
|
Phase 3 | |
Recruiting |
NCT05408078 -
Become Your Own SLEEPexpert: a Behavioral Treatment Program for Insomnia in Patients With Psychiatric Disorders
|
N/A | |
Recruiting |
NCT05780983 -
Sleep Well 24 (SWELL24) Healthy Sleep-Wake Behaviors in Older Adults
|
N/A | |
Completed |
NCT03575104 -
Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep
|
Phase 3 | |
Not yet recruiting |
NCT06279286 -
Phase Ⅰb/Ⅱ Study of HS-10506 in Chinese Participants With Insomnia Disorder
|
Phase 1/Phase 2 | |
Terminated |
NCT02571595 -
A Sleep Program to Improve Sleep Quality in People With HIV
|
N/A | |
Completed |
NCT00984698 -
A Trial of Group Psychotherapy for Veterans and Military Personnel With Post Traumatic Stress Disorder (PTSD)
|
N/A | |
Recruiting |
NCT05780177 -
Brief Behavioral Treatment for Insomnia in Veterans With Posttraumatic Stress Disorder
|
N/A |